Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research
Top Cited Papers
Open Access
- 31 January 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Clinical Epidemiology
- Vol. 118, 1-8
- https://doi.org/10.1016/j.jclinepi.2019.10.003
Abstract
No abstract availableKeywords
Funding Information
- EORTC Quality of Life Group (008 2014)
- Austrian Science Fund (FWF #P26930)
This publication has 18 references indexed in Scilit:
- Implementation of Patient-Reported Outcomes in Routine Medical CareAsco Educational Book, 2018
- Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocolBMJ Open, 2018
- Evaluating patients for psychosocial distress and supportive care needs based on health-related quality of life in primary brain tumors: a prospective multicenter analysis of patients with gliomas in an outpatient settingJournal of Neuro-Oncology, 2016
- Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30European Journal Of Cancer, 2012
- Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs)Breast Cancer Research and Treatment, 2011
- Symptoms and problems in a nationally representative sample of advanced cancer patientsPalliative Medicine, 2009
- Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomesJournal of Clinical Epidemiology, 2007
- Measuring Quality of Life in Routine Oncology Practice Improves Communication and Patient Well-Being: A Randomized Controlled TrialJournal of Clinical Oncology, 2004
- Quality of life research within the EORTC—the EORTC QLQ-C30European Journal Of Cancer, 2002
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993